Navigation Links
St. Jude identifies genomic causes of a certain type of leukemia relapse
Date:11/27/2008

and be responsible for relapse."

According to the researchers, the relapse-related genetic changes commonly disrupted the machinery by which white blood cells called B cells mature and proliferate. Importantly, the relapse-related genetic changes only infrequently involved genes directly regulating the responsiveness to anti-cancer drugs.

The analysis also indicated that in most cases, the cancer cells responsible for relapse were related to those that originally gave rise to the cancer. Those relapse cells were present at low levels at diagnosis, the scientists' analysis indicated. However, in a few cases, the relapse cells evolved from genetically distinct cells, indicating that the relapsed leukemia was actually an entirely new cancer.

"The key finding in our work is that in the majority of cases, relapse is arising from a cell already present at the time of diagnosis," said James Downing, M.D., St. Jude Scientific Director, chair of the Department of Pathology and the paper's senior author. "That cell is selected for during treatment and then subsequently emerges as basis for relapse."

"The second key point is that we have found a large number of new genetic alterations that had not been previously identified as new targets of copy number changes at the time of relapse," Mullighan added.

Mullighan emphasized that the findings do not mean immediate treatments for ALL relapse. "But, this is a very important starting point because we have identified several key pathways that are the most common targets of new genetic changes at the time of relapse," he said.

Identification of these relapse pathways will lead to understanding of the biological machinery of relapse, and ultimately to drugs that target that machinery. Such studies of the relapse machinery are now underway at St. Jude.

In other further studies, the researchers are also looking for other relapse-related genetic alterations besides copy num
'/>"/>

Contact: Summer Freeman
summer.freeman@stjude.org
901-595-3061
St. Jude Children's Research Hospital
Source:Eurekalert

Page: 1 2 3

Related biology news :

1. LSUHSC research identifies key contributor to Alzheimers disease process
2. Pitt research identifies new target in brain for treating schizophrenia
3. Research identifies type of vaccine that holds promise in protecting against TB
4. Conaway Lab identifies novel mechanism for regulation of gene expression
5. HPV DNA test identifies cervical pre-cancerous disease in developing countries with 90% success rate
6. New method identifies meth hot spots
7. Study identifies changes to DNA in major depression and suicide
8. UCLA study identifies mechanism behind mind-body connection
9. International team identifies 21 new genetic risk factors for Crohns disease
10. Stowers Institutes Shilatifard Lab identifies new role for factor critical to transcription
11. Rong Li Lab identifies new role of inflammatory protein in PKD and a possible treatment
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/24/2015)... , Feb. 24, 2015 Research and ... the addition of the "Global 2D Gesture ... The analysts forecast the Global ... CAGR of 32.12% over the period 2014-2019 ... in non-traditional sectors is one of the major ...
(Date:2/18/2015)... SUNNYVALE, Calif. , Feb. 18, 2015  Cepheid (NASDAQ: ... be speaking at the following conferences, and invited investors to ... Conference, Boston, MA Tuesday, March 3, ... Institutional Investors Conference, Orlando, FL Wednesday, ... Accessing Live Webcasts To access the live webcasts for these ...
(Date:2/12/2015)... 12, 2015 NXT-ID, Inc. (NASDAQ: ... biometric authentication company focused on the growing mobile commerce ... 62/113114 for DISTRIBUTED METHOD AND SYSTEM TO ... patent further establishes NXT-ID,s position in the emerging "Internet ... the ability for multiple devices to collaborate with one ...
Breaking Biology News(10 mins):Global 2D Gesture Recognition Market 2015-2019 with Cognitec Systems, CogniVue, eyeSight Mobile Technologies & PointGrab Dominating 2Cepheid to Webcast Upcoming Financial Presentations 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 2NXT-ID Patents Collaborative Services to Enable the "Internet of Things" 3
... 2 emissions from using coal are set to double by ... mitigating global climate change. In view of the essential role ... emissions where coal is used. The British Geological ... (NZEC) Phase 1 study in Beijing, China today. The aim of ...
... engineering students Shahzeen Attari, Ines Margarida Lima de Azevedo, ... a letter-writing competition called Tomorrows Energy Ambassadors, Managers and ... ... students to demonstrate their awareness of important energy and ...
... in Spanish . , Researchers from the ... of the University of Granada ( UGR ) ... iron and steel industry workers. Continuous exposure to certain ... discussed in the course Technologies for Industrial Waste Treatment ...
Cached Biology News:UK scientists lead China closer to carbon capture and storage 2Carnegie Mellon students win contest 2Carnegie Mellon students win contest 3Scientists develop a fast system to detect metal concentrations in iron and steel industry workers 2
(Date:3/3/2015)... 2015 /CNW/- SQI Diagnostics Inc. (TSX:V: SQD), a life sciences ... products for advanced microarray diagnostics, today announced it ... its Management team. In his capacity as CFO ... from a development stage to a commercially successful ... Company,s capital market strategy and to secure funding ...
(Date:3/3/2015)... -- Fried, Frank, Harris, Shriver & Jacobson LLP announced ... the Firm as a partner in the Intellectual Property ... office. Mr. Lewis concentrates on patent litigation ... intellectual property and general litigation. A trained chemical engineer ... and defendants in a range of technology-related sectors but ...
(Date:3/3/2015)... , March 3, 2015  Rosa & Co. ... drug-disease modeling and simulation research, today announced it has ... American Society for Clinical Pharmacology and Therapeutics meeting in ... 2015.   Logo - http://photos.prnewswire.com/prnh/20150302/179058LOGO   ... will present a poster describing a quantitative systems pharmacology ...
(Date:3/3/2015)... 03, 2015 Cambridge Semantics, the leading ... technology, today announced that it has been named to ... in Knowledge Management.’ , To create the list ... analysts and system integrators who identify organizations dedicated to ... right information to the right people at the right ...
Breaking Biology Technology:SQI Diagnostics Appoints Chief Financial Officer 2SQI Diagnostics Appoints Chief Financial Officer 3Leading Patent Attorney Jeffrey Lewis Joins Fried Frank's Intellectual Property Litigation Practice 2Leading Patent Attorney Jeffrey Lewis Joins Fried Frank's Intellectual Property Litigation Practice 3Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting 2Rosa & Co. Announces Two Poster Presentations at the American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting 3Cambridge Semantics Named to KMWorld’s 2015 ‘100 Companies That Matter in Knowledge Management’ 2
... In a strategic effort to refocus and strengthen ... a regimen of planning to make adjustments in the ... The announcement is made by Denise Brown, FRA Interim ... involves augmenting our board of directors with four of ...
... DermTech, a biotechnology company developing non-invasive molecular diagnostics ... from a study showing that its novel melanoma ... qRT-PCR platform.  Strong earlier results using microarrays have ... discriminated melanoma with 100% sensitivity and 85% specificity. ...
... Inc. (NYSE Amex: PTN ), a biopharmaceutical ... of diseases with significant unmet medical need and commercial ... September 30, 2011. Palatin reported a net loss of ... for the quarter ended September 30, 2011, compared to ...
Cached Biology Technology:Fitzsimons Redevelopment Authority Rolls Out First Phase of Strategic Refocus With Appointment of Four Key Leaders in The Bioscience Industry to Its Board of Directors 2DermTech's Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study 2DermTech's Non-invasive Melanoma Detection Assay Poised to Enter Clinical Validation Study 3Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011 2Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011 3Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011 4Palatin Technologies, Inc. Reports First Quarter Fiscal Year 2012 Results; Teleconference and Webcast to be held on November 15, 2011 5
HiTrap NHS-activated HP, 1 x 5 ml. Category: Chromatography Systems & Accessories, Systems....
Human OSCAR MAb (Clone 259501)...
Human/Mouse G9a/EHMT2 MAb (Clone A8620A) Keywords: Eu-HMTase2...
Human M-CSF...
Biology Products: